The impact of sacubitril/valsartan on outcome in patients suffering from heart failure with a concomitant diabetes mellitus
Abstract Background Guidelines classify sacubitril/valsartan as a significant part of medical treatment of heart failure with reduced ejection fraction (HFrEF). Data have shown that the HbA1c levels in patients with diabetes mellitus could be impacted by sacubitril/valsartan. A possible positive eff...
Збережено в:
| Автори: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Oxford University Press
2023-04-01
|
| Серія: | ESC Heart Failure |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1002/ehf2.14239 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|